Anti-tuberculosis

Tuberculosis continues to be one of the world’s deadliest diseases, affecting over 10 million people worldwide, and still causing 1.7 million deaths yearly. Rooted in our profound belief that the fight against TB requires commitment from private sector partners, we are working together with the Stop TB partnership, and the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM), to supply high-quality Swissmedic-approved anti-tuberculosis medicines. We are listed as an approved supplier to multiple UN/WHO agencies, GFATM, and the Global Drug Facility (GDF). We continue to expand our anti-tuberculosis product portfolio, and aim to remain a key partner in the global fight against TB.
  • Isoniaz-TB
  • Myambutol
  • Pyrazinamide
  • Rifampicin

Get in touch

Get in touch with us at info@labatec.com

For other enquiries, please visit our contact page.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.